Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence

Infection and Immunity

Volumn 79, Issue 6, 2011, Pages 2335-2344

  Vigil, Patrick D ^a   Alteri, Christopher J ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL RNA; GENOMIC DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC SCREENING; KATG BACTERIAL GENE; KIDNEY INFECTION; KPSS BACTERIAL GENE; LOLA BACTERIAL GENE; LOLD BACTERIAL GENE; MOUSE; NARJI BACTERIAL GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROWX BACTERIAL GENE; TOSA BACTERIAL GENE; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; YDDQ BACTERIAL GENE; YDHX BACTERIAL GENE;

ANIMALS; ANTIGENS, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENOMIC LIBRARY; HUMANS; MICE; MICE, INBRED CBA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 79959435729     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00110-11     Document Type: Article

References (41)

1. Aboderin, O. A., A. R. Abdu, B. W. Odetoyin, and A. Lamikanra. 2009. Antimicrobial resistance in Escherichia coli strains from urinary tract infections. J. Natl. Med. Assoc. 101:1268-1273.
2. Alteri, C. J., E. C. Hagan, K. E. Sivick, S. N. Smith, and H. L. Mobley. 2009. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5:e1000586.
3. Alteri, C. J., and H. L. Mobley. 2007. Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine. Infect. Immun. 75:2679-2688.
4. Alteri, C. J., S. N. Smith, and H. L. Mobley. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog. 5:e1000448.
5. Bahrani-Mougeot, F. K., et al. 2002. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol. Microbiol. 45:1079-1093.
6. Bours, P. H., et al. 2010. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int. J. Infect. Dis. 14:e770-e774.
7. Brzuszkiewicz, E., et al. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103:12879-12884.
8. Chakupurakal, R., M. Ahmed, D. N. Sobithadevi, S. Chinnappan, and T. Reynolds. 2010. Urinary tract pathogens and resistance pattern. J. Clin. Pathol. 63:652-654.
9. Chambers, S. T., and C. M. Kunin. 1987. Isolation of glycine betaine and proline betaine from human urine. Assessment of their role as osmoprotective agents for bacteria and the kidney. J. Clin. Invest. 79:731-737.
10. Culham, D. E., et al. 1998. Osmoregulatory transporter ProP influences colonization of the urinary tract by Escherichia coli. Microbiology 144:91- 102.
11. Culham, D. E., et al. 2001. The osmotic stress response and virulence in pyelonephritis isolates of Escherichia coli: contributions of RpoS, ProP, ProU and other systems. Microbiology 147:1657-1670.
12. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
13. Deb, D. K., P. Dahiya, K. K. Srivastava, R. Srivastava, and B. S. Srivastava. 2002. Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis (Edinburgh) 82:175-182.
14. Dielubanza, E. J., and A. J. Schaeffer. 2011. Urinary tract infections in women. Med. Clin. North Am. 95:27-41.
15. Foxman, B. 2002. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl. 1A):5S-13S.
16. Griebling, T. L. 2005. Urologic diseases in America project: trends in resource use for urinary tract infections in women. J. Urol. 173:1281-1287.
17. Haardt, M., B. Kempf, E. Faatz, and E. Bremer. 1995. The osmoprotectant proline betaine is a major substrate for the binding-proteindependent transport system ProU of Escherichia coli K-12. Mol. Gen. Genet. 246:783-786.
18. Hagan, E. C., A. L. Lloyd, D. A. Rasko, G. J. Faerber, and H. L. Mobley. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog. 6:e1001187.
19. Hagan, E. C., and H. L. Mobley. 2007. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection. Infect. Immun. 75:3941-3949.
20. Hagberg, L., et al. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
21. Hang, L., et al. 2003. Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc. Natl. Acad. Sci. U. S. A. 100:8508-8513.
22. John, M., et al. 2005. Use of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection. Infect. Immun. 73:2665-2679.
23. Kumar, M., et al. 2011. Identification of Mycobacterium tuberculosis genes preferentially expressed during human infection. Microb. Pathog. 50:31-38.
24. Leblond-Francillard, M., J. L. Gaillard, and P. Berche. 1989. Loss of catalase activity in Tn1545-induced mutants does not reduce growth of Listeria monocytogenes in vivo. Infect. Immun. 57:2569-2573.
25. Leeds, J. A., and R. A. Welch. 1996. RfaH enhances elongation of Escherichia coli hlyCABD mRNA. J. Bacteriol. 178:1850-1857.
26. Lloyd, A. L., T. A. Henderson, P. D. Vigil, and H. L. Mobley. 2009. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J. Bacteriol. 191:3469-3481.
27. Mobley, H. L., et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
28. Nielubowicz, G. R., and H. L. Mobley. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7:430-441.
29. Parham, N. J., et al. 2005. Prevalence of pathogenicity island II CFT073 genes among extraintestinal clinical isolates of Escherichia coli. J. Clin. Microbiol. 43:2425-2434.
30. Rollins, S. M., et al. 2005. In vivo induced antigen technology (IVIAT). Cell. Microbiol. 7:1-9.
31. Salim, K. Y., et al. 2005. Identification of group A streptococcus antigenic determinants upregulated in vivo. Infect. Immun. 73:6026-6038.
32. Sivick, K. E., and H. L. Mobley. 2009. An "omics" approach to uropathogenic Escherichia coli vaccinology. Trends Microbiol. 17:431-432.
33. Sivick, K. E., and H. L. Mobley. 2010. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78:568-585.
34. Smith, S. N., E. C. Hagan, M. C. Lane, and H. L. Mobley. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio 1:e00262-10.
35. Smith, Y. C., S. B. Rasmussen, K. K. Grande, R. M. Conran, and A. D. O'Brien. 2008. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. Immun. 76:2978-2990.
36. Soler-Garcia, A. A., and A. E. Jerse. 2007. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response. Infect. Immun. 75:2225-2233.
37. Trifillis, A. L., et al. 1994. Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli. Kidney Int. 46:1083-1091.
38. Warren, J. (ed.). 1996. Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, DC.
39. Welch, R. A., et al. 2002. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:17020-17024.
40. Welch, R. A., E. P. Dellinger, B. Minshew, and S. Falkow. 1981. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature 294:665- 667.
41. Wood, J. M. 1999. Osmosensing by bacteria: signals and membrane-based sensors. Microbiol. Mol. Biol. Rev. 63:230-262.